Filing Details

Accession Number:
0001214659-25-004753
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-25 16:30:09
Reporting Period:
2025-03-21
Filing Date:
2025-03-25
Accepted Time:
2025-03-25 16:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Royalty Corp XOMA Pharmaceutical Preparations (2834) 522154066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1959809 Bradley Sitko C/O Xoma Royalty Corporation
2200 Powell Street, Suite 310
Emeryville CA 94608
Chief Investment Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-21 1,334 $20.65 10,484 No 4 P Direct
Depositary Shares - 8.375% B Cumulative Stock Acquisiton 2025-03-21 2,800 $25.43 2,800 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
8.625% Series A Cumulative Perpetual Preferred Stock 313 Direct
Common Stock 829 Indirect By 401(k)
Common Stock 1,500 Indirect By spouse
Common Stock 75 Indirect By child
Common Stock 75 Indirect By child
8.625% Series A Cumulative Perpetual Preferred Stock 82 Indirect By spouse
Depositary Shares - 8.375% B Cumulative Stock 2,000 Indirect By spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $20.60 to $20.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $25.42 to $25.46. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.